New Day Diagnostics: Clinical Trials

7 trials sponsored by New Day Diagnostics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 active not recruiting, 1 recruiting. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 5

Follow New Day Diagnostics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
mSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis
Circulating mSEPT9 Biomarker Testing - Hepatocellular Carcinoma (HCC), Cirrhosis
RecruitingCentral Hospital, Nancy, France4002025-06-032026-06-10
Q-POC SARS-CoV-2 Assay COVID-19 Clinical Evaluation
RT-PCR Test, Real-time PCR Test - COVID-19
Not applicableCompletedQuantuMDx Group Ltd8772022-11-282024-02-28
CRC Detection Reliable Assessment With Blood
Next-Gen CRC Screening Test - Colorectal Cancer, Adenomas Colon
Active not recruitingNew Day Diagnostics1962022-09-082026-11-10
COVID-19 iCura SARS-CoV-2 Ag OTC: Clinical Evaluation
iCura COVID-19 Antigen Rapid Home Test, RT-PCR Test - SARS-CoV-2 Infection, COVID-19
Not applicableCompletedNew Day Diagnostics1002022-08-042023-02-15
COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation
iCura COVID-19 Antigen Rapid Home Test, RT-PCR Test - SARS-CoV2 Infection, COVID-19
Not applicableCompletedMP Biomedicals, LLC3322021-12-092023-06-01
COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability
Rapid SARS-CoV-2 Antigen Test - Sars-CoV-2 Infection, COVID-19
Not applicableCompletedMP Biomedicals, LLC992021-10-072023-06-02
Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis
"Epi proColon 2.0 CE" test from Epigenomics, Inc (Berlin, Germany) - Hepatocellular Carcinoma, Cirrhosis
Not applicableCompletedCentral Hospital, Nancy, France6392018-02-122026-06-10

Conditions studied

COVID-19 (4)  ·  Carcinoma, Hepatocellular (2)  ·  Fibrosis (2)  ·  Adenoma (1)  ·  Colonic Diseases (1)  ·  Colonic Diseases, Functional (1)  ·  Colonic Neoplasms (1)  ·  Colonic Polyps (1)  ·  Colorectal Neoplasms (1)  ·  Gastrointestinal Neoplasms (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)  ·  Polyps (1)  ·  Rectal Diseases (1)  ·  Rectal Neoplasms (1)

Countries

United States (5)  ·  France (2)

Top investigators

Jason Liggett, PhD (3)  ·  Alice Neilson (1)  ·  Jason Liggett, PhD. (1)  ·  Mr. Franck Schreiner (1)